123 related articles for article (PubMed ID: 20307197)
1. ACB-PCR quantification of K-RAS codon 12 GAT and GTT mutant fraction in colon tumor and non-tumor tissue.
Parsons BL; Marchant-Miros KE; Delongchamp RR; Verkler TL; Patterson TA; McKinzie PB; Kim LT
Cancer Invest; 2010 May; 28(4):364-75. PubMed ID: 20307197
[TBL] [Abstract][Full Text] [Related]
2. A subset of papillary thyroid carcinomas contain KRAS mutant subpopulations at levels above normal thyroid.
Myers MB; McKim KL; Parsons BL
Mol Carcinog; 2014 Feb; 53(2):159-67. PubMed ID: 22930660
[TBL] [Abstract][Full Text] [Related]
3. A novel high-specificity approach for colorectal neoplasia: Detection of K-ras2 oncogene mutation in normal mucosa.
Yamada S; Yashiro M; Maeda K; Nishiguchi Y; Hirakawa K
Int J Cancer; 2005 Mar; 113(6):1015-21. PubMed ID: 15514939
[TBL] [Abstract][Full Text] [Related]
4. ACB-PCR measurement of K-ras codon 12 mutant fractions in livers of Big Blue rats treated with N-hydroxy-2-acetylaminofluorene.
McKinzie PB; Delongchamp RR; Chen T; Parsons BL
Mutagenesis; 2006 Nov; 21(6):391-7. PubMed ID: 17012303
[TBL] [Abstract][Full Text] [Related]
5. Temporal changes in K-ras mutant fraction in lung tissue of big blue B6C3F₁ mice exposed to ethylene oxide.
Parsons BL; Manjanatha MG; Myers MB; McKim KL; Shelton SD; Wang Y; Gollapudi BB; Moore NP; Haber LT; Moore MM
Toxicol Sci; 2013 Nov; 136(1):26-38. PubMed ID: 24029818
[TBL] [Abstract][Full Text] [Related]
6. [K-ras mutational status and tumour-infiltrating lymphocytes in human colon cancer: state of the art and future perspectives].
Kocián P; Sedivcová M; Drgáč J; Cerná K; Hoch J; Kodet R; Bartůňková J; Spíšek R; Fialová A
Rozhl Chir; 2012 Aug; 91(8):427-32. PubMed ID: 23153426
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of K-Ras codon 12 mutations in the F344 rat distal colon following azoxymethane exposure.
McKinzie PB; Parsons BL
Environ Mol Mutagen; 2011 Jun; 52(5):409-18. PubMed ID: 21370285
[TBL] [Abstract][Full Text] [Related]
8. ACB-PCR quantification of somatic oncomutation.
Myers MB; McKinzie PB; Wang Y; Meng F; Parsons BL
Methods Mol Biol; 2014; 1105():345-63. PubMed ID: 24623241
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy.
Oltedal S; Aasprong OG; Møller JH; Kørner H; Gilje B; Tjensvoll K; Birkemeyer EM; Heikkilä R; Smaaland R; Nordgård O
Int J Colorectal Dis; 2011 Oct; 26(10):1271-7. PubMed ID: 21573767
[TBL] [Abstract][Full Text] [Related]
10. [Sensitive detection of K-ras oncogene codon 12 mutations by nested PCR using mismatched primers and selective digestion of non-mutated PCR fragments with restriction enzyme].
Fukayama N; Sugano K; Kyogoku A; Nose H; Kondou H; Ohkura H
Rinsho Byori; 1993 Sep; 41(9):1017-23. PubMed ID: 8254964
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of K-ras codon 12 mutation in patients with resected gallbladder cancer.
Kazmi HR; Chandra A; Nigam J; Noushif M; Parmar D; Gupta V
Dig Surg; 2013; 30(3):233-9. PubMed ID: 23838952
[TBL] [Abstract][Full Text] [Related]
12. [Screening for K-ras mutations in colorectal and lung cancers by using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing].
Zhang HP; Fu L; Chen PQ; Ye YB; Ji TH; Zheng LM
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):757-61. PubMed ID: 21215167
[TBL] [Abstract][Full Text] [Related]
13. Rapid detection of K-ras mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis: comparison with restriction fragment length polymorphism analysis.
Chen CY; Shiesh SC; Wu SJ
Clin Chem; 2004 Mar; 50(3):481-9. PubMed ID: 14718395
[TBL] [Abstract][Full Text] [Related]
14. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
[TBL] [Abstract][Full Text] [Related]
15. [Detection of point mutations of C-Ki-ras oncogene in colon cancer by PCR using specific oligonucleotide probes].
Xu KM
Zhonghua Zhong Liu Za Zhi; 1992 Jul; 14(4):261-3. PubMed ID: 1396073
[TBL] [Abstract][Full Text] [Related]
16. Comparative screening of K-ras mutations in colorectal cancer and lung cancer patients using a novel real-time PCR with ADx-K-ras kit and Sanger DNA sequencing.
Zhang H; Zheng X; Ji T; Fu L; Bai D; Liao Y; Zhang H; Ding Y; Zheng L
Cell Biochem Biophys; 2012 Apr; 62(3):415-20. PubMed ID: 22048888
[TBL] [Abstract][Full Text] [Related]
17. [Mutations of APC and K-ras gene in aberrant crypt foci from human colon].
Yuan P; Sun M; Zhang J; Zhu X; Shi D
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):35-8. PubMed ID: 11866955
[TBL] [Abstract][Full Text] [Related]
18. Does a cost-effective approach for the determination of KRAS mutations maximize the patient's benefit in a clinical setting?
Kobunai T; Watanabe T; Yamamoto Y; Fukusato T
Pharmacogenomics; 2011 Mar; 12(3):307-8; author reply 309-10. PubMed ID: 21449668
[No Abstract] [Full Text] [Related]
19. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]